JPWO2023032955A5 - - Google Patents
Info
- Publication number
- JPWO2023032955A5 JPWO2023032955A5 JP2023545587A JP2023545587A JPWO2023032955A5 JP WO2023032955 A5 JPWO2023032955 A5 JP WO2023032955A5 JP 2023545587 A JP2023545587 A JP 2023545587A JP 2023545587 A JP2023545587 A JP 2023545587A JP WO2023032955 A5 JPWO2023032955 A5 JP WO2023032955A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- amino acid
- seq
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021140932 | 2021-08-31 | ||
| PCT/JP2022/032523 WO2023032955A1 (ja) | 2021-08-31 | 2022-08-30 | 抗成長ホルモン抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023032955A1 JPWO2023032955A1 (https=) | 2023-03-09 |
| JPWO2023032955A5 true JPWO2023032955A5 (https=) | 2025-09-02 |
Family
ID=85411222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545587A Pending JPWO2023032955A1 (https=) | 2021-08-31 | 2022-08-30 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240391996A1 (https=) |
| EP (1) | EP4397762A4 (https=) |
| JP (1) | JPWO2023032955A1 (https=) |
| CN (1) | CN117881784A (https=) |
| TW (1) | TW202323289A (https=) |
| WO (1) | WO2023032955A1 (https=) |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| CA2095633C (en) | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Enrichment method for variant proteins with altered binding properties |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| US7264963B1 (en) | 1995-08-18 | 2007-09-04 | Morphosys Ag | Protein(poly)peptide libraries |
| US5945296A (en) * | 1996-03-29 | 1999-08-31 | Pharmacia & Upjohn Ab | Monoclonal antibody |
| SE9601231D0 (sv) * | 1996-03-29 | 1996-03-29 | Pharmacia Ab | Monoclonal antibody |
| JPH10191974A (ja) * | 1997-01-16 | 1998-07-28 | Mitsui Chem Inc | ヒト成長ホルモンに特異的に反応するモノクローナル抗体 |
| ES2327382T3 (es) | 1999-07-20 | 2009-10-29 | Morphosys Ag | Metodos para presentar (poli)peptidos/proteinas en particulas de bacteriofagos a traves de enlaces disulfuro. |
| US7083784B2 (en) | 2000-12-12 | 2006-08-01 | Medimmune, Inc. | Molecules with extended half-lives, compositions and uses thereof |
| MXPA05000511A (es) | 2001-07-12 | 2005-09-30 | Jefferson Foote | Anticuepros super humanizados. |
| US7217797B2 (en) | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
-
2022
- 2022-08-30 JP JP2023545587A patent/JPWO2023032955A1/ja active Pending
- 2022-08-30 US US18/687,607 patent/US20240391996A1/en active Pending
- 2022-08-30 CN CN202280057692.6A patent/CN117881784A/zh active Pending
- 2022-08-30 TW TW111132650A patent/TW202323289A/zh unknown
- 2022-08-30 EP EP22864537.0A patent/EP4397762A4/en active Pending
- 2022-08-30 WO PCT/JP2022/032523 patent/WO2023032955A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230242651A1 (en) | Stable antibody variable domain framework combinations | |
| JP2023539245A5 (https=) | ||
| AU2022241522B2 (en) | Bispecific antibody to a-syn/igf1r and use thereof | |
| JP2023509448A5 (https=) | ||
| US20250282879A1 (en) | Multispecific antibodies having specificity for il-4r and il-31 | |
| RU2013115927A (ru) | АНТИТЕЛА ПРОТИВ ИЛ-1β И СПОСОБЫ ПРИМЕНЕНИЯ | |
| JP2013507115A5 (https=) | ||
| JP2021530244A5 (https=) | ||
| US11365240B2 (en) | Anti-HSA antibodies | |
| JP2022523507A5 (https=) | ||
| JP2024105229A5 (https=) | ||
| RU2014123030A (ru) | Антагонистические антитела против человеческого рецептора гормона роста и способы их применения | |
| JP2024515560A5 (https=) | ||
| JP2022500455A5 (https=) | ||
| JP2022531552A5 (https=) | ||
| JP2025506341A5 (https=) | ||
| JPWO2023032955A5 (https=) | ||
| US20250388665A1 (en) | Anti-tnf-alpha antibodies and compositions | |
| JP2023548471A5 (https=) | ||
| JP2023512827A5 (https=) | ||
| JPWO2021162098A5 (https=) | ||
| US20260098100A1 (en) | Il-4r and tslp inhibitors and methods of use thereof | |
| US20250154242A1 (en) | Anti-tnf-alpha antibodies and compositions | |
| EP4019090A1 (en) | Antibody variable domains that bind il-4r | |
| WO2024038095A1 (en) | NOVEL ANTI-RGMb ANTIBODIES |